Lindsay A Renfro

Point estimation following two‐stage adaptive threshold enrichment clinical trials

Nigel Stallard, Susan Todd, Peter K Kimani, 2018, Statistics in medicine.

Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection

Nigel Stallard, Susan Todd, Ekkehard Glimm, 2020, Statistics in medicine.

Impact of Copula Directional Specification on Multi-Trial Evaluation of Surrogate End Points

Daniel J Sargent, Hongwei Shang, Lindsay A Renfro, 2015, Journal of biopharmaceutical statistics.

Bayesian adjusted R2 for the meta‐analytic evaluation of surrogate time‐to‐event endpoints in clinical trials

Bradley P Carlin, Daniel J Sargent, Qian Shi, 2012, Statistics in medicine.

Definitions and statistical properties of master protocols for personalized medicine in oncology

Sumithra J Mandrekar, Lindsay A Renfro, S. Mandrekar, 2018, Journal of biopharmaceutical statistics.

Precision oncology: A new era of cancer clinical trials.

Sumithra J Mandrekar, Lindsay A Renfro, Ming-Wen An, 2017, Cancer letters.

Clinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database.

Daniel J Sargent, Christophe Tournigand, Eduardo Diaz-Rubio, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer.

Daniel J Sargent, Greg Yothers, Lindsay A Renfro, 2014, Journal of the National Cancer Institute.

Adaptive randomized phase II design for biomarker threshold selection and independent evaluation.

Daniel J Sargent, Lindsay A Renfro, D. Sargent, 2014, Chinese clinical oncology.